adjuvant treatment - Robuta Search

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1487353/full Frontiers | Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a... BackgroundThe five-year recurrence rate for patients with hepatocellular carcinoma (HCC) is as high as 70%. Patients with high-risk recurrence factors experi... adjuvant treatment https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-adjuvant-treatment-stage-iibc-melanoma FDA approves nivolumab for adjuvant treatment of Stage IIB/C melanoma | FDA On October 13, 2023, the Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) for the adjuvant treatment of completely... adjuvant treatment fda approves nivolumab https://pmc.ncbi.nlm.nih.gov/articles/PMC7699469/ Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer - PMC Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous standard of care. This is... adjuvant treatment colorectal cancer statistical considerations trials https://www.aacr.org/patients-caregivers/progress-against-cancer/nivolumab-approved-for-neoadjuvant-and-adjuvant-treatment-of-non-small-cell-lung-cancer/ Nivolumab Approved for Neoadjuvant and Adjuvant Treatment of NSCLC | Research | AACR Oct 21, 2024 - The immunotherapy nivolumab is now approved as a treatment for certain non-small cell lung cancers before and after surgery. adjuvant treatment nivolumab approved neoadjuvant https://www.preprints.org/manuscript/202509.2595 Adjuvant Treatment for Surgically-Treated Cervical Cancer Patients: A Comprehensive Review[v1] |... Cervical cancer (CC) is the fourth most common gynecologic malignancy, affecting dis-proportionately women in low- and middle-income countries. Despite the... adjuvant treatment cervical cancer https://www.nice.org.uk/guidance/ta684/chapter/2-Information-about-nivolumab 2 Information about nivolumab | Nivolumab for adjuvant treatment of completely resected melanoma... Evidence-based recommendations on nivolumab (Opdivo) for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease... information about adjuvant treatment 2 nivolumab https://www.scielo.org.mx/scielo.php?script=sci_abstract&pid=S1665-11462019000500215&lng=en&nrm=iso&tlng=en Extended-release vinpocetine: a possible adjuvant treatment for focal onset epileptic seizures extended release adjuvant treatment https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-01113 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer - NCI Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer non small cell lung cancer adjuvant treatment https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-01113&r=1 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer - NCI Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer non small cell lung cancer adjuvant treatment https://www.healthday.com/dermatology-special/second-course-of-adjuvant-treatment-feasible-in-stage-iii-to-iv-melanoma Second Course of Adjuvant Treatment Feasible in Stage 3 to 4 Melanoma For patients with stage III to IV melanoma, a second course of adjuvant treatment is feasible, but recurrence-free survival is lower with anti-programmed cell... second course adjuvant treatment https://www.nice.org.uk/guidance/ta612 Overview | Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive... Evidence-based recommendations on neratinib (Nerlynx) for extended adjuvant treatment of hormone receptor-positive, human epidermal growth factor receptor 2... hormone receptor positive adjuvant treatment overview neratinib extended https://www.mdpi.com/2306-7381/12/6/541 Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders:... Faecal microbiota transplantation (FMT) has emerged as a transformative therapy in human medicine, particularly for managing recurrent Clostridioides difficile... adjuvant treatment faecal microbiota transplantation disorders https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-cemiplimab-rwlc-adjuvant-treatment-cutaneous-squamous-cell-carcinoma?ref=sinodrugwatch.com FDA approves cemiplimab-rwlc for adjuvant treatment of cutaneous squamous cell carcinoma | FDA On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc.) for the adjuvant treatment of adults... cemiplimab rwlc adjuvant treatment https://www.nice.org.uk/guidance/ta684/history History | Nivolumab for adjuvant treatment of completely resected melanoma with lymph node... Evidence-based recommendations on nivolumab (Opdivo) for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease... adjuvant treatment https://www.southampton.ac.uk/research/projects/pathos-post-operative-adjuvant-treatment-for-hpv-positive-tumours PATHOS: Post-operative adjuvant treatment for HPV-positive tumours | University of Southampton PATHOS: Post-operative adjuvant treatment for HPV-positive tumours. post operative adjuvant treatment https://www.rti.org/publication/cost-utility-nivolumab-versus-observation-adjuvant-treatment-urothelial-carcinoma-uc-0 Cost-utility of nivolumab versus observation for the adjuvant treatment of urothelial carcinoma... https://pmc.ncbi.nlm.nih.gov/articles/PMC6440723/ Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected... This phase 2, multi-institutional clinical trial assesses whether patients with resected primary gastrointestinal stromal tumor receiving 5 years of adjuvant... https://www.elsevier.es/en-revista-cirugia-espanola-english-edition--436-articulo-local-excision-for-organ-preservation-S2173507724001194 Local Excision for organ preservation in early REctal cancer with No Adjuvant treatment (LORENA... IntroductionLocal resection (LR) is an alternative to total mesorectal excision https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.706861/full Frontiers | Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery Breast cancer is one of the most prevalent type of cancers worldwide, especially for females. Surgery is the preferred treatment for breast cancer, and vario... cardiac toxicity https://www.mdpi.com/1660-4601/20/1/462 Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed... Objective: To analyse the overall effectiveness and cost-efficiency of a mobile application (APP) as a community health asset (HA) with recommendations and...